IPOPLUS

₹810

▲ +21.95 +2.79%

16 Jun 2026

BSE Listed

Riddhi Siddhi Gluco Biols (524480)

Volume: 9,531Avg Vol 1W: 2,929Avg Vol 1M: 3,03752W Range:₹490₹761
BSE
Key Ratios
Updated just now
Market Cap₹457 Cr
Current Price₹810
Previous Close₹788.05
High / Low (52w)₹761 / ₹490
Volume9,531
Avg Vol (1W)2,929
Avg Vol (1M)3,037
Stock P/E5.76
Book Value₹2,155.44
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)—
P/B0.3
Debt / Equity—
50 DMA₹652.62
200 DMA₹546.55
Day change+2.79%
Price Chart
₹810▲ 39.66% · 1Y
₹818₹41121K
2025-06-18
2026-06-16

20-day avg volume: 3K shares

Pros
  • Revenue grew 74% YoY.
  • Stock trades below its book value.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue₹9 Cr₹40 Cr₹32 Cr₹155 Cr₹28 Cr—
EBITDA₹3 Cr₹9 Cr₹24 Cr₹21 Cr₹23 Cr—
Net Profit₹-26 Cr₹-1 Cr₹14 Cr₹8 Cr₹4 Cr—
EPS-45.92-1.8119.2911.276.49—
Profit & Loss (Annual)
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Revenue₹236 Cr₹136 Cr₹268 Cr₹172 Cr—
EBITDA₹56 Cr₹90 Cr₹84 Cr₹86 Cr—
Net Profit₹-4 Cr₹5 Cr₹47 Cr₹-56 Cr—
EPS—-17.0661.53-119.13.12
Balance Sheet
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Total Assets₹1,891 Cr₹1,784 Cr₹1,774 Cr₹1,692 Cr—
Total Liabilities₹352 Cr₹198 Cr₹182 Cr₹202 Cr—
Equity₹1,509 Cr₹1,549 Cr₹1,537 Cr₹1,432 Cr—
Total Debt₹283 Cr₹101 Cr₹73 Cr₹81 Cr—
Cash Flow
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Operating₹-9 Cr₹-28 Cr₹9 Cr₹1 Cr—
Investing₹-22 Cr₹21 Cr₹21 Cr₹8 Cr—
Financing₹140 Cr₹8 Cr₹-41 Cr₹2 Cr—
Free Cash Flow₹-10 Cr₹-77 Cr₹-4 Cr₹0 Cr—

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search